Snapshot from Jul 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Dupilumab
Other

Dupilumab

Tracked across 1 events · 6 articles · First seen Apr 13, 2026 · Last active Jul 30, 2026

Sentiment
80
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 80
Business
Sanofi Q2 2026 earnings beat
Sanofi reported Q2 2026 results with sales growth of 17.8% at CER and business EPS of €2.09, up 33.3% at CER. Dupilumab sales exceeded €5 billion for the first time, growing 37.6%. Pharma launches sales…
Impact: Dupilumab sales grew 37.6% to €5.2 billion in Q2, exceeding €5 billion quarterly for the first time. It is a key growth driver, with expected 2030 sales of ~€25 billion.
Jul 30, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Dupilumab live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.